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Improvements to medical practice and delivery of treatment has been the focus of many international
collaborations aiming to address the delivery of appropriate health care in low- and middle-income countries.
However, this is compounded by various social, cultural as well as resource allocation issues. This Editorial marks the
launch of an article collection on Medicine for Global Health (http://www.biomedcentral.com/bmcmed/series/
medicine_for_global_health), and here, guest editor Gretchen Birbeck discusses the challenges, importance and
increasing relevance of global health.Editorial
“Global health” refers to issues related to population
health that, due to the common multi-national nature of
the issue or its scientific implications, have relevance be-
yond a single country’s borders. Given the broad deter-
minants of human health, “global health” topics span a
vast spectrum of disciplines compared to with traditional
Western medicine. By its very nature, global health must
grapple with problems that transcend care provision at
the individual patient level. Global health includes ill-
defined intersections among human and veterinary
medicine (the basic and the clinical), sociology, anthro-
pology, bioethics, environmental health, health services
research, economics and the political sciences [1]. Even
this list is not exhaustive. Global health is difficult to de-
fine—and yet we know it when we see it. Or so our edi-
torial team thinks. We hope you agree.
Much that is published in the global health literature
addresses the challenges of public health improvements
and healthcare delivery in resource-limited settings. Of
course, resources for optimizing health and providing
healthcare are virtually always limited in some fashion.
But the term “resource-limited setting” is usually used to
refer to situations in which the lack of resources is soCorrespondence: birbeck@msu.edu
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reproduction in any medium, provided the orextreme that the effect of the resource limitation itself
becomes one of the central challenges to be assessed.
Like the term “global health”, the term “resource-limited
setting” is also amorphous. It can describe a community
with food insecurity so severe as to result in increased
child mortality or it can be a label used to bemoan the
lack of neuroimaging capacity to study cerebral malaria
in endemic regions. Dissecting the layers of deprivation
and deprivation’s impact on human health in resource-
limited settings is one of the many challenges of provid-
ing healthcare services and conducting research in such
circumstances.
In recent years, the interest in global health from the
general public as well as the academic community has
skyrocketed. In the first decade of 2000, the number of
US medical schools offering international electives more
than doubled [2]. Many domestic philanthropic organiza-
tions from wealthy nations have expanded into low income,
tropical settings [3]. International aid for development as-
sistance was $5.2 billion in 1990, had increased to $21.8 bil-
lion by 2007 [3], and even in the face of a global recession,
this investment continues to rise. What has stimulated this
growing interest? The HIV/AIDS pandemic and subse-
quent moral imperative to facilitate treatment access be-
yond wealthy nations undoubtedly drew attention to other
healthcare issues that transcend national borders. Philan-
thropists like Bill and Melinda Gates certainly deserve
credit for directing their substantial wealth and personalhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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global health. But perhaps our interest in people and prob-
lems beyond our own immediate communities has been
most affected by the interconnectedness that characterizes
this electronic age.
Simple interventions may be one of the themes of the
article collection Medicine for Global Health, published
in BMC Medicine. We learn from a systematic review
that hypothermia preventive measures could decrease
neonatal mortality rates, since neonatal hypothermia can
indirectly contribute to this mortality rate [4]. In another
research article, Srinivasan et al. [5] report a randomized
controlled trial of zinc supplements in children with se-
vere pneumonia. They found an overall case fatality rate
of 4% in the zinc-treated children versus 11.9% in those
receiving placebo, with the protective effect being
greatest for children with HIV. And Hall et al. [6] detail
the importance of including nutritional support as a key
component of any intervention, particularly community-
based mass treatment programs, aimed at the neglected
tropical diseases (NTDs). The sad reality is that what
many clinicians most need to help their patients is the
capacity to write a prescription for adequate nutrition.
Despite the substantial investments made in the provision
of improved access to drugs for conditions including HIV/
AIDS, malaria, and NTDs, many of our patients are trying
to take these medications on a chronically empty stomach.
Maybe “hunger” should be added to the list of NTDs.
Tools developed by the World Health Organization
(WHO)-convened expert groups, which are aimed at op-
timizing healthcare services, have been highlighted in
Katchanov’s article on epilepsy care guidelines for low-
and middle-income countries [7] as well as the guide for
analysts by Jit et al. [8] on economic evaluations of the
human papillomavirus (HPV) vaccine. HPV cost analyses
are the focus of Hutubessy et al. [9] and Quentin et al.
[10], contributions that both detail economic analyses of
the costs of delivery and scale-up of the vaccine to girls
in Tanzania, where cervical cancer is the number one
cancer-related cause of death among women. Taking ad-
vantage of planning tools developed by the WHO,
Hutubessy et al. found that the principal marginal costs
are those associated with social mobilization. Accessing
girls who are beyond the typical age for scheduled vacci-
nations for a three-dose vaccine requires some invest-
ment, but school-based scale-up could cost as little as ~
$26/girl including the cost of the vaccine and the salaries
of existing staff [10]. Studies like these suggest there are
feasible, cost-effective options for decreasing cancer-
related mortalities in countries where cervical cancer is
a major killer.
Finally, Maitland et al. [11] offer a closer look at data
from the Fluid Expansion as Supportive Therapy
(FEAST) trial. The original FEAST study surprised mostof us with its finding that fluid boluses are associated
with excess mortality at 48 hours in African children
with sepsis. To shed some light on the pathophysiologic
mechanisms underlying this excess mortality, Maitland
et al. looked at all-cause mortality by clinical presenta-
tion, hemodynamic changes in the first hour and ter-
minal clinical events. The authors hypothesized that
excess mortality would be mediated by fluid overload.
FEAST continues to surprise us. The excess mortality
appears to be related to refractory shock, not fluid over-
load, suggesting that an ischemia-reperfusion injury fol-
lowing resuscitation may be the problem. Elucidating
the mechanism of death in this population of African
children has implications for pediatric emergency care
measures in all settings, which is further highlighted in a
commentary by Simon Finfer and John Myburgh [12].
We seem to have a lot to learn, even about “simple”
interventions.
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